Witryna12 paź 2024 · little or no urinating, swelling in your feet or ankles, feeling tired or short of breath (signs of kidney problems). Common Lipitor side effects may include: joint pain; stuffy nose, sore throat; diarrhea; or. … Witryna2 kwi 2024 · 23. Lipitor is the best-selling drug in history. (STAT News, FiercePharma) Lipitor generated a staggering $94.67 billion in sales from 1992–2024. Even though this cholesterol and heart disease medication decreased in popularity after its patent expired in 2011, Lipitor still brings a nice chunk of the profit to Pfizer.
The Lowdown on Lipitor (atorvastatin): What You Need To …
Witryna27 lip 2024 · Matej Mikulic. During 2024, Pfizer’s Lipitor generated nearly two billion U.S. dollars of revenue. For around a decade cholesterol-lowering drug Lipitor was one of … Witryna11 paź 2024 · Experts estimate that this Indian company has about 60 percent of the market for the most popular statin-type cholesterol-lowering drug. That is why it has … endangered animals beginning with x
Crestor: Uses, Side Effects, Dosages, Interactions - Verywell Health
Witryna31 mar 2024 · Here’s a closer look at common concerns with statins like atorvastatin (Lipitor), pravastatin (Pravachol), rosuvastatin (Crestor) and simvastatin (Zocor) — and when you need to worry, or not. CONCERN: Statins can have a lot of side effects, including muscle pain, digestive problems and liver damage. WitrynaThe global statin market size reached US$ 14.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach US$ 18.1 Billion by 2028, exhibiting a growth rate (CAGR) of 3.2% during 2024-2028. Statin is a lipid-lowering medication, an agent that is consumed by patients to reduce their blood cholesterol levels. WitrynaLipitor is used together with diet to lower lipids (fats) known as cholesterol and triglycerides in the blood in patients with various types of hypercholesterolaemia (high blood cholesterol levels). It is also used for the prevention of a first cardiovascular event (such as a heart attack) in patients considered to be at high risk. dr byron mcclure